Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Determining the acceptable level of physician compliance with a treat-to-target strategy in early rheumatoid arthritis
Author: Wabe, N.
Sorich, M.
Wechalekar, M.
Cleland, L.
Mcwilliams, L.
Lee, A.
Spargo, L.
Metcalf, R.
Hall, C.
Proudman, S.
Wiese, M.
Citation: International Journal of Rheumatic Diseases, 2017; 20(5):576-583
Publisher: Wiley
Issue Date: 2017
ISSN: 1756-1841
Statement of
Nasir Wabe, Michael J. Sorich, Mihir D. Wechalekar, Leslie G. Cleland, Leah McWilliams, Anita Lee, Llewellyn Spargo, Robert Metcalf, Cindy Hall, Susanna M. Proudman and Michael D. Wiese
Abstract: Objective: To determine the minimum cut-points for rate of physician compliance with a treat-to-target (T2T) strategy needed to achieve optimal rates of remission or low disease activity (LDA). Method: In this analysis of longitudinal observational data from patients with early RA, physician compliance with a T2T treatment protocol was determined for each clinic visit over 3 years. Remission and LDA were measured by Disease Activity Score in 28 joints (DAS28), simplified disease activity index (SDAI) and clinical disease activity index (CDAI). The minimum physician compliance rates for predicting these outcomes were calculated using receiver operating characteristic (ROC) curves. Result: Overall, 149 patients completed 3078 clinic visits over 3 years of follow-up. Treatment decisions complied with the T2T protocol in 2343 of these visits (76.1%). The minimum cut-points for physician compliance rates that predicted remission and LDA according to DAS28 were 81.1% and 70.7%, respectively, and to predict remission and LDA according to SDAI, the respective cut-points were 92.7% and 77.4%. Based on these cut-points, three categories of physician compliance with T2T were proposed: high (to maximize the likelihood of achieving remission, > 80% according to DAS28 or > 90% according to SDAI/CDAI); medium (the minimal physician compliance to achieve LDA, 70-79% according to DAS28 or 75-89% for SDAI/CDAI); and low (< 70% for DAS28 and < 75% for SDAI/CDAI), where remission and LDA are unlikely). When patients were stratified by baseline disease activity, the physician compliance rate cut-points were similar for most outcomes at year 3. Conclusion: Using real-life clinical data, we determined the thresholds for physician compliance with a T2T strategy that stratified patients according to their disease outcomes and proposed a system for classifying physician compliance as high, medium and low.
Keywords: Cut-off value; physician compliance; rheumatoid arthritis; ROC curve; treat-to-target
Rights: © 2015 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd
DOI: 10.1111/1756-185X.12816
Appears in Collections:Aurora harvest 8
Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.